XYLO-PFAN Drug Patent Profile
✉ Email this page to a colleague
When do Xylo-pfan patents expire, and what generic alternatives are available?
Xylo-pfan is a drug marketed by Savage Labs and is included in one NDA.
The generic ingredient in XYLO-PFAN is xylose. There is one drug master file entry for this compound. Additional details are available on the xylose profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for XYLO-PFAN?
- What are the global sales for XYLO-PFAN?
- What is Average Wholesale Price for XYLO-PFAN?
Summary for XYLO-PFAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 128 |
| Patent Applications: | 2,393 |
| DailyMed Link: | XYLO-PFAN at DailyMed |
US Patents and Regulatory Information for XYLO-PFAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Savage Labs | XYLO-PFAN | xylose | POWDER;ORAL | 017605-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
